Breaking News
January 23, 2018 - Findings provide better understanding of cognitive inflexibility in Fragile X Syndrome
January 23, 2018 - Powerful anti-oxidant can stop progression of fatty liver disease in young mice
January 23, 2018 - Study shows value of occupational therapy in the lives of young adults with diabetes
January 23, 2018 - Researchers seek to understand effect of very low birth weight on the brain
January 23, 2018 - Be a Savvy Supermarket Shopper
January 23, 2018 - NIH Striving to Avoid False Hope in Chronic Fatigue
January 23, 2018 - ClinicalTrials.gov: Occupational Stress
January 23, 2018 - PrEP could make US easily hit its 2020 HIV prevention goal, study finds
January 23, 2018 - Study finds considerable variation in hip fracture rates across nursing homes
January 23, 2018 - Evidence-based approach to preventing or treating caries could transform dental care
January 22, 2018 - TAVR Discharge Timing; Stentreiver Anesthesia; New Valve Depression
January 22, 2018 - Could sugar be responsible for the obesity and diabetes epidemics?
January 22, 2018 - Mallinckrodt Completes Stannsoporfin New Drug Application Filing
January 22, 2018 - ACOG Backs ‘Cascade Testing’ for Cancer-Related Mutations
January 22, 2018 - The terrible toll tennis can take on top players who play too much
January 22, 2018 - KAIST scientists identify cellular mechanism for severe viral hepatitis
January 22, 2018 - New genomic tools provide better understanding of the human immune system
January 22, 2018 - Improving QoL with an App?
January 22, 2018 - Researchers identify virus as likely cause of mystery polio-like paralysis
January 22, 2018 - First step toward CRISPR cure of Lou Gehrig’s disease
January 22, 2018 - Scientists uncover the proteins responsible for movement
January 22, 2018 - New clinical practice guideline provides recommendations for use of anticoagulants during heart surgery
January 22, 2018 - Depressive symptoms associated with poorer survival in patients with head and neck cancer
January 22, 2018 - Restaurant Bans Have Big Impact on Smoking Rates
January 22, 2018 - D.C. Week: CMS Outlines Path for Medicaid Work Mandate
January 22, 2018 - Study identifies new loci associated with asthma enriched in epigenetic marks
January 22, 2018 - Researchers explore impact of smart rollator in motivating seniors to increase physical activity
January 22, 2018 - New bug may reduce misery of hay fever sufferers
January 22, 2018 - Specially prepared supplement helps women to run faster, study shows
January 22, 2018 - 3-D Stent Retriever with Aspiration Proves Mettle in AIS
January 22, 2018 - Public health research seeks to understand how natural disasters impact spread of Zika
January 22, 2018 - Research reveals role of nanophenomenon in stimulating bone-repair process
January 22, 2018 - Drinking during late adolescence could be first step to liver problems in adulthood
January 22, 2018 - Epilepsy associated with volume and thickness differences in brain matter
January 22, 2018 - Trevena Announces FDA Acceptance for Review of New Drug Application for Olinvo (oliceridine) Injection
January 22, 2018 - A Noteworthy Margin of Error
January 22, 2018 - Firm advances human trials of revolutionary vaccine
January 22, 2018 - Many Indians put away treating orthopedic problems
January 22, 2018 - Cherwell releases new pocket guide to prepared culture media
January 22, 2018 - Huron earns ISO 13485 certification for quality management system
January 22, 2018 - Avion Pharmaceuticals Announces FDA Approval of Balcoltra (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets) Oral Contraceptive
January 22, 2018 - Multi-Gene Test For Early CVD; Neighborhood HF Risk; Novel Testosterone Drugs
January 22, 2018 - Skipping breakfast disrupts ‘clock genes’ that regulate body weight
January 22, 2018 - Creativity May Rely on ‘Teamwork’ in the Brain
January 22, 2018 - NeuroBreak: Alzheimer’s Germ Contest; High Salt Diet May Be Bad for Brain
January 22, 2018 - Diabetics may often fare poorly in hospice care
January 22, 2018 - Performance enhancing benefits of caffeine more apparent for infrequent tea, coffee drinkers
January 22, 2018 - HHS Unveils Framework for Interoperability
January 22, 2018 - More dentists to discuss risks of HPV-related cancers with their patients
January 21, 2018 - Research shows how Zika virus damages placenta to cause malformations in babies
January 21, 2018 - Achaogen Announces FDA Acceptance of New Drug Application with Priority Review for Plazomicin for Treatment of Complicated Urinary Tract Infections and Bloodstream Infections
January 21, 2018 - Drug Allergies: Time to Re-Test?
January 21, 2018 - Mitochondrial protein in cardiac muscle cells linked to heart failure, study finds
January 21, 2018 - Women more likely than men to die from a heart attack
January 21, 2018 - Next generation genomic sequencing can help detect pathogens after joint replacement
January 21, 2018 - Gov’t Shutdown Looms as Senate Debates Spending Bill
January 21, 2018 - Emergency Readiness for Older Adults and People with Disabilities
January 21, 2018 - Heart health at risk for Latinas over worries about deportation
January 21, 2018 - Scientists methodically identify genes related to blood feeding and non-biting mosquitoes
January 21, 2018 - Researchers discover potential target genes to halt thyroid cancer progression
January 21, 2018 - Youth with shared residency after parents’ divorce have less mental issues
January 21, 2018 - Sleep Better, Lose Weight? – Drugs.com MedNews
January 21, 2018 - More $$ Needed for Health Emergencies, Senators Told
January 21, 2018 - Gene test to predict breast cancer recurrence less cost effective in real world practice
January 21, 2018 - Study finds rise in number of adolescents receiving psychiatric or neurodevelopmental diagnosis
January 21, 2018 - Reminders can improve immunization rates
January 21, 2018 - A More Personalized Approach to PSA Screening in 2017
January 21, 2018 - T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma
January 21, 2018 - Tetraphase Pharmaceuticals Announces Submission of New Drug Application to FDA for Eravacycline for the Treatment of Complicated Intra-Abdominal Infections (cIAI)
January 21, 2018 - Have Robotics Had a Detrimental Effect on Surgical Residency?
January 21, 2018 - Being bilingual may help autistic children
January 21, 2018 - Metrics Are Not Widespread in Rheumatoid Care
January 21, 2018 - Neuroanatomic abnormalities ID’d in those at risk for autism
January 21, 2018 - Children born with Down’s syndrome have superior genome that compensates for disability
January 21, 2018 - Study finds higher risks for asymptomatic paroxysmal AF patients
January 21, 2018 - The Second Stage of Diet Resolutions
January 21, 2018 - CT Scans Reduce Lung Cancer Deaths … But Among Whom?
January 21, 2018 - ADHD drug use soars among young women
January 21, 2018 - Researchers propose new regulation mechanism linked to action of SirT6 on chromatin
January 21, 2018 - Statins appear to reduce risk of repeated surgery in patients who undergo vitrectomy
New global trial to test whether exercise could be prescribed alongside prostate cancer treatment

New global trial to test whether exercise could be prescribed alongside prostate cancer treatment

image_pdfDownload PDFimage_print

Queen’s University Belfast are taking part in a global trial to test whether exercise should be prescribed to treat patients with advanced prostate cancer.

The Global Action Plan 4 Global Prostate Cancer (GAP4) will bring together 150 researchers around the world to share their expertise to improve the life chances of prostate cancer patients and is led by The Movember Foundation.

A pilot study carried out by the Edith Cowan University in Western Australia in 2016 demonstrated that high intensity training could be a powerful tool to prolong the lives of prostate cancer patients. Dr Nicolas Hart, who led the research commented: “The study was able to show that a high intensity exercise program was safe, feasible, and enjoyed by advanced prostate cancer patients, including those with bone metastases, while preserving their physical function and improving their quality of life. We are delighted that these observational findings will allow us to rigorously test whether exercise can extend patient survival using a high intensity exercise program in a worldwide study thanks to an investment of £8.84m Australian dollars (over £5.1m) from the Movember Foundation.”

The global clinical trial aims to recruit 866 patients across three continents in a collaborative effort to share data and biological samples by leading scientists and clinicians to accelerate health outcomes for men with prostate cancer. Men with advanced prostate cancer will be placed on a high intensity exercise regime, tailored to their level of fitness. Researchers will work together to determine if high intensity aerobic and resistance training alongside the ‘standard’ psycho-social support offered to prostate cancer patients will lead to increased overall survival.

Dr Gillian Prue, who is leading the study at Queen’s University Belfast, said: “We know already that physical activity plays a significant factor in maintaining our health and fitness. Exercise can help alleviate the common symptoms associated with having cancer treatment such as pain and fatigue, but we are now delighted to be working with experts around the world to not only to help men with prostate cancer feel better, but to try and actually boost survival rates. The overall aim is that exercise will be prescribed alongside traditional treatments such as radiotherapy and chemotherapy at a global level.”

Dr Suneil Jain from Queen’s University added: “This is very exciting research. Many standard treatments cause side-effects including weight gain and loss of muscle bulk. High intensity interval training may make men fitter, improve their quality of life and even prolong their survival. This study is the largest of its kind ever to be performed in prostate cancer.”

Queen’s University have been awarded additional funding from the Health and Social Care Research and Development Division (HSC R&D) of the Public Health Agency (PHA) to target patients with advanced prostate cancer who would otherwise be excluded from the research. Dr Prue said: “High intensity training may not be suitable for all men with advanced prostate cancer, particularly among those with additional health conditions. Alongside the global intervention, in collaboration with Professor Marie Murphy an exercise scientist from Ulster University, we will develop a low intensity walking program for men who cannot participate in the Movember trial to assess the feasibility of low intensity exercise as a way to improve the quality of life and reduce symptom burden for these men.” Dr Janice Bailie, Assistant Director of the HSC R&D Division of the Public Health Agency added: “This initiative represents an excellent co-funding opportunity to support the availability of the global GAP4 study to patients in Northern Ireland. It also enables those patients not suitable for participation in the main study to become involved in a program with similar potential benefits.”

886aad80-d241-4c00-bac9-435e5fa16924|0|.0

Posted in: Men’s Health News | Medical Research News

Tags: Bone, Cancer, Cancer Treatment, Chemotherapy, Clinical Trial, Exercise, Fatigue, Muscle, Pain, Physical Activity, Prostate, Prostate Cancer, Public Health, Radiotherapy, Social Care, Walking

Tagged with:

About author

Related Articles